CoChat
Sign Up
Cited by 16

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Malignant hematopoietic cell lines: in vitro models for the study of anaplastic large-cell lymphoma

Drexler, H G, MacLeod, R A F·2004·Leukemia
DOI 10.1038/sj.leu.2403465
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.leu.2403465

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 2 references

Research works printed but not linked: 34

  1. Lamant L, Espinos E, Duplantier M, Dastugne N, Robert A, Allouche M et al. Establishment of a novel anaplastic large cell lymphoma-cell line (COST) from a small cell variant of ALCL. Leukemia 2004, 18: 1693–1698. · DOI
  2. Stein H, Mason DY, Gerdes J, O’Connor N, Wainscoat J, Pallesen G et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed–Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848–858. · DOI
  3. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML et al. Revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392. · DOI
  4. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting – Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849. · DOI
  5. Drexler HG, Gignac SM, von Wasielewski R, Werner M, Dirks WG . Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Leukemia 2000; 14: 1533–1559. · DOI
  6. Stein H, Foss HD, Durkop H, Marafioti T, Delsol G, Pulford K et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000; 96: 3681–3695. · DOI
  7. Falini B . Anaplastic large cell lymphoma: pathological, molecular and clinical features. Br J Haematol 2001; 114: 741–760. · DOI
  8. Kadin ME, Morris SW . The t(2;5) in human lymphomas. Leukemia Lymphoma 1998; 29: 249–256. · DOI
  9. Duyster J, Bai RY, Morris SW . Translocations involving anaplastic lymphoma kinase (ALK). Oncogene 2001; 20: 5623–5637. · DOI
  10. Horie R, Watanabe M, Ishida T, Koiwa T, Aizawa S, Itoh K et al. The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma. Cancer Cell 2004; 5: 353–364. · DOI
  11. Drexler HG, Matsuo Y, MacLeod RAF . Continuous hematopoietic cell lines as model systems for leukemia–lymphoma research. Leukemia Res 2000; 24: 881–911. · DOI
  12. Nezelof C, Barbey S, Gogusev J, Terrier–Lacombe MJ . Malignant histiocytosis in childhood: a distinctive CD30-positive clinicopathological entity associated with a chromosomal translocation involving 5q35. Semin Diagn Pathol 1992; 9: 75–89.
  13. Gogusev J, Nezelof C . Malignant histiocytosis. Histologic, cytochemical, chromosomal, and molecular data with a nosologic discussion. Hematol Oncol Clin North Am 1998; 12: 445–463. · DOI
  14. Herbst H, Drexler HG . CD30-positive anaplastic large cell lymphoma cell lines. In: Masters JRW, Palsson BO (eds) Human Cell Culture, Vol. III – Cancer Cell Lines Part 3: Leukemias and Lymphomas. Dordrecht: Kluwer Academic Publishers, 2000, pp 355–370.
  15. Drexler HG (ed). The Leukemia–Lymphoma Cell Line FactsBook. San Diego: Academic Press, 2000.
  16. Dirks WG, Zaborski M, Jager K, Challier C, Shiota M, Quentmeier H et al. The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines. Leukemia 1996; 10: 142–149.
  17. Shiota M, Fujimoto J, Semba T, Satoh H, Yamamoto T, Mori S . Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. Oncogene 1994; 9: 1567–1574.
  18. Barbey S, Gogusev J, Mouly H, Le Pelletier O, Smith W, Richard S et al. DEL cell line: a ‘malignant histiocytosis’ CD30+ t(5;6)(q35;p21) cell line. Int J Cancer 1990; 45: 546–553. · DOI
  19. Kubonishi I, Sonobe H, Miyagi T, Iwahara Y, Ohyashiki JH, Ohyashiki K et al. A Ki-1 (CD30)-positive T (E+, CD4+, Ia+)-cell line, DL-40, established from aggressive large cell lymphoma. Cancer Res 1990; 50: 7682–7685.
  20. Del Mistro A, Leszl A, Bertorelle R, Calabro ML, Panozzo M, Menin C et al. A CD30-positive T cell line established from an aggressive anaplastic large cell lymphoma, originally diagnosed as Hodgkin's disease. Leukemia 1994; 8: 1214–1219.
  21. Al-Hashmi I, Decoteau J, Gruss HJ, Zielenska M, Thorner P, Poon A et al. Establishment of a cytokine-producing anaplastic large-cell lymphoma cell line containing the t(2;5) translocation: potential role of cytokines in clinical manifestations. Leukemia Lymphoma 2001; 40: 599–611. · DOI
  22. Su IJ, Balk SP, Kadin ME . Molecular basis for the aberrant expression of T cell antigens in postthymic T cell malignancies. Am J Pathol 1988; 132: 192–198.
  23. Kadin ME, Cavaille-Col MW, Sioutos N, Fletcher JA, Morton CC, Pastuzak W et al. Childhood Ki-1+ anaplastic large cell lymphoma: establishment and characterization of a new tumor cell line transplantable to SCID mice. Blood 1990; 76: 354a. · DOI
  24. Schiemann WP, Pfeifer WM, Levi E, Kadin ME, Lodish HF . A deletion in the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T-cell lymphoma. Blood 1999; 94: 2854–2861. · DOI
  25. Fischer P, Nacheva E, Mason DY, Sherrington PD, Hoyle C, Hayhoe FG et al. A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene. Blood 1988; 72: 234–240. · DOI
  26. Shimakage M, Dezawa T, Tamura S, Tabata T, Aoyagi N, Koike M et al. A Ki-1-positive cell line expressing Epstein–Barr virus antigens, established from a child with Ki-1-positive lymphoma. Intervirology 1993; 36: 215–224. · DOI
  27. Merz H, Lange K, Gaiser T, Muller A, Kapp U, Bittner C et al. Characterization of a novel human anaplastic large cell lymphoma cell line tumorigenic in SCID mice. Leukemia Lymphoma 2002; 43: 165–172. · DOI
  28. Su IJ, Kadin ME . Expression of growth factor/receptor genes in postthymic T cell malignancies. Am J Pathol 1989; 135: 439–445.
  29. Rimokh R, Magaud JP, Berger F, Samarut J, Coiffier B, Germain D et al. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (‘Ki-1 lymphoma’). Br J Haematol 1989; 71: 31–36. · DOI
  30. Epstein AL, Kaplan HS . Biology of the human malignant lymphomas I Establishment in continuous cell culture and heterotransplantation of diffuse histiocytic lymphomas. Cancer 1974; 34: 1851–1872. · DOI
  31. Morgan R, Smith SD, Hecht BK, Christy V, Mellentin JD, Warnke R et al. Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis. Blood 1989; 73: 2155–2164. · DOI
  32. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994; 263: 1281–1284. · DOI
  33. Umiel T, Rettenmier CW, Siegel S, Ota S, Shimada H, Tran TW et al. Establishment and characterization of a human mixed-lineage, T-lymphoid/myeloid cell line (USP-91). Blood 1993; 82: 1829–1837. · DOI
  34. Al-Katib A, Abubakr Y, Mohamed A, Maki A, Diurec Z, Mohammad R . Multiple mechanisms of drug resistance in anaplastic large cell lymphoma. Blood 1994; 84: 638a. · DOI

Cited by

See all 16

Metadata

Authors
Drexler, H. G., & MacLeod, R. A. F.
Venue
Leukemia
Publisher
Springer Science and Business Media LLC
Published
2004-09-09
Volume
18
Issue
10
Pages
1569-1571
ISSN
  • 0887-6924
  • 1476-5551
DOI
10.1038/sj.leu.2403465
Cited by
16
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Malignant hematopoietic cell lines: in vitro models for the study of anaplastic large-cell lymphoma. https://app.cochat.ai/papers/10.1038/sj.leu.2403465
The paper
Drexler, H. G., & MacLeod, R. A. F. (2004). Malignant hematopoietic cell lines: in vitro models for the study of anaplastic large-cell lymphoma. Leukemia. https://doi.org/10.1038/sj.leu.2403465